BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30901891)

  • 1. Non-Metastatic Esophageal Adenocarcinoma: Circulating Tumor Cells in the Course of Multimodal Tumor Treatment.
    Kuvendjiska J; Bronsert P; Martini V; Lang S; Pitman MB; Hoeppner J; Kulemann B
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30901891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytopathological Heterogeneity of Circulating Tumor Cells in Non-metastatic Esophageal Adenocarcinoma.
    Kuvendjiska J; Pitman MB; Martini V; Braun C; Grebe K; Timme S; Fichtner-Feigl S; Glatz T; Schmoor C; Guenzle J; Hoeppner J; Kulemann B
    Anticancer Res; 2020 Oct; 40(10):5679-5685. PubMed ID: 32988893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
    Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells found in patients with localized and advanced pancreatic cancer.
    Kulemann B; Pitman MB; Liss AS; Valsangkar N; Fernández-Del Castillo C; Lillemoe KD; Hoeppner J; Mino-Kenudson M; Warshaw AL; Thayer SP
    Pancreas; 2015 May; 44(4):547-50. PubMed ID: 25822154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential Isolation and Characterization of Single CTCs and Large CTC Clusters in Metastatic Colorectal Cancer Patients.
    Francescangeli F; Magri V; De Angelis ML; De Renzi G; Gandini O; Zeuner A; Gazzaniga P; Nicolazzo C
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
    Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
    PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
    Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
    Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
    Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
    Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery.
    Wu ZJ; Tan JC; Qin X; Liu B; Yuan ZC
    Cancer Manag Res; 2018; 10():3333-3339. PubMed ID: 30237736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRAS mutations in pancreatic circulating tumor cells: a pilot study.
    Kulemann B; Liss AS; Warshaw AL; Seifert S; Bronsert P; Glatz T; Pitman MB; Hoeppner J
    Tumour Biol; 2016 Jun; 37(6):7547-54. PubMed ID: 26684803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer.
    Brungs D; Lynch D; Luk AW; Minaei E; Ranson M; Aghmesheh M; Vine KL; Carolan M; Jaber M; de Souza P; Becker TM
    World J Gastroenterol; 2018 Feb; 24(7):810-818. PubMed ID: 29467551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulatory Tumor Cells in Esophageal Adenocarcinoma.
    Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():177-186. PubMed ID: 29600370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and clinicopathological significance of circulating tumor cells in osteosarcoma.
    Li M; Lu Y; Long Z; Li M; Kong J; Chen G; Wang Z
    J Bone Oncol; 2019 Jun; 16():100236. PubMed ID: 31024791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer.
    Yu P; Zhu S; Luo Y; Li G; Pu Y; Cai B; Zhang C
    J Oncol; 2022; 2022():9635218. PubMed ID: 35058982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform.
    Tsutsuyama M; Nakanishi H; Yoshimura M; Oshiro T; Kinoshita T; Komori K; Shimizu Y; Ichinosawa Y; Kinuta S; Wajima K; Sakakibara Y; Yatabe Y; Ito S; Kodera Y
    PLoS One; 2019; 14(2):e0212221. PubMed ID: 30811434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients.
    Zeinali M; Lee M; Nadhan A; Mathur A; Hedman C; Lin E; Harouaka R; Wicha MS; Zhao L; Palanisamy N; Hafner M; Reddy R; Kalemkerian GP; Schneider BJ; Hassan KA; Ramnath N; Nagrath S
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.